REDUCED TREATMENT ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIABETES MELLITUS USING NEWER ANTI-DIABETIC MEDICATIONS: AN ANALYSIS FROM THE EPI-IIRN
Yuri Gorelik 1
Chagit Friss 2
Itamar Koren
Dima Shlon
Yiska Loewenberg Weisband 3
Amir Ben-Tov 4
Shira Greenfeld
Unknown Unknown 5
Eran Matz 6
Iris Dotan 7
Dan Turner
Haggai Bar-Yoseph
1 Rambam Health Care Campus, Haifa, Israel
2 Shaare Zedek Medical Center, Jerusalem, Israel
3 Clalit Health Services, Tel-Aviv, Israel
4 Maccabi Health Services, Tel-Aviv, Israel
5 Meuhedet Health Services, Tel-Aviv, Israel
6 Leumit Health Services, Tel-Aviv, Israel
7 Rabin Medical Center, Petah Tikva, Israel
Topic
IBD
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]